-
New England's largest coal plant will operate until 2024
Time of Update: 2023-01-02
The Merrimack coal plant, which has an installed capacity of nearly 439 megawatts and was first commissioned in 1960, has been called for by activists to shut down, and the average capacity factor at its peak in 2018 was 14%.
-
Literature sharing: Which is safer for the treatment of rheumatoid arthritis, JAK inhibitor or tumor necrosis factor inhibitor
Time of Update: 2022-11-25
To compare the incidence of safety endpoints between study groups, namely cardiovascular (CV) events, tuberculosis (TB), total hip replacement (THR), total knee replacement (TKR), and all-cause mortality.
-
Taking a variety of micronutrients can improve cognition in older adults
Time of Update: 2022-10-19
The "Investigation Report on the Awareness and Demand of Alzheimer's Disease in China" was recently released. The survey report shows that the total awareness rate of Alzheimer's disease (AD) in Chin
-
Professors Wu Depei and Zhang Xi: Concentric relay, continuing hope, innovative ADC drug Pola opens up a new pattern suitable for transplanted R/R DLBCL treatment
Time of Update: 2022-10-14
GuideEvery opening of the unknown world has the brave foresight of pioneers; Every journey of sneaking in the dark night, there is a little lamp man fearlessly leading the way. The series of reports "
-
J Immunother Cancer: Association of lower autoantibody levels with immune-related adverse events caused by immune checkpoint inhibitors
Time of Update: 2022-04-18
Source: Ghosh N, Postow M, Zhu C, Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.
J Immunother Cancer 2022 01;10(1)Ghosh N, Postow M, Zhu C,Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition.
-
2020 China's petroleum and chemical industry market status and development prospect forecast
Time of Update: 2022-01-06
According to national* data, as of the end of 2019, there were 26,271 enterprises above designated size in the petroleum and chemical industry, a year-on-year decrease of 5.
-
Amgen postpones the launch of Samsung's Enbrel biosimilar to 2029
Time of Update: 2022-01-01
According to the latest judgment, Samsung Bioepis will not be able to manufacture, sell or import Enbrel biosimilar drugs in the United States before 2029 .
-
AP&T: Analysis of the prevalence and risk factors of ruminant syndrome and functional dyspepsia in the general community
Time of Update: 2021-12-03
In addition, the researchers also found that diet may help reduce the symptoms of ruminant syndrome and FD, and may have a therapeutic effect on both diseases .
-
And yellow medicine second treatment of advanced non-pancreatic neuroendocrine tumor new drug approved in sight
Time of Update: 2021-01-15
, Sovantini's application for adaptation to the treatment of advanced non-pancreatic neuroendocrine tumors is based on data from clinical studies SANET-ep.
addition, Voliteni has also submitted a domestic application for the launch of a new drug for non-small cell lung cancer ("NSCLC") with a 14-hop mutation in the exon exon of inter-therapeutic persetretic endoscopic conversion factor ("MET").
-
European Commission approves TREMFYA ® (guselkumab) for the treatment of active psoriasis arthritis (PsA
Time of Update: 2020-12-14
Johnson and Johnson Pharmaceuticals announced today that the European Commission (EC) has approved TREMFYA® (guselkumab) for the treatment of adult patients with active psoriasis arthritis (PsA), who are not responsive or insufficiable to previous treatments for anti-disease rheumatoid drugs (DMARD).
-
The development of T-cell response spectrum helps to understand immune diseases
Time of Update: 2020-07-22
researchers at Wellcome Sanger Institute, GSK, Biogen and open targets have found that T cells respond to immune signals very differently after exposure to more "training", rather than simply transiting from naive to experienced.
-
Proteomics research reveals new therapeutic targets for new coronary pneumonia
Time of Update: 2020-05-30
On May 14, 2020, researchers from the University of Frankfurt and Goethe University published their latest research on SARS-CoV-2 infection characteristics and potential therapeutic targets for COVID-
-
Ann Rheum Dis: The Efficacy of Rheumatoid Arthritis Medication: 2019 Updated Guidelines for the Treatment of Rheumatoid Arthritis
Time of Update: 2020-05-29
The study aims to inform the European Union against Rheumatoid (EULAR) guidelines for the treatment of rheumatoid arthritis (RA) updated in 2019 conducted a systematic literature study (SLR) by r
-
In the first half of this year, the R & D investment of these four pharmaceutical enterprises totaled 7.273 billion yuan
Time of Update: 2019-09-17
[pharmaceutical network industry trends] innovation to pharmaceutical enterprises is like a source to a stream Driven by the policies of "4 + 7" with volume procurement and consistency evaluation, inn
-
FDA approval of Bayer kogenate FS for routine prevention of hemophilia
Time of Update: 2014-05-14
Source: Biovalley announced on May 13, 2014 that the new indication of anti hemophilia factor VIII (recombinant) kogenate FS was approved by FDA for routine prevention of adult patients with hemophili
